MedTrace Logo

Prospective Study To Assess The Safety and Efficacy of the PROW LIF Procedure

NCT01850537 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2013-05-09

No results posted yet for this study

Summary

This is a prospective, single-arm, open-label, non-randomized study. The aim of the study is to assess the safety and efficacy of the Prow LIF procedure in Transforaminal Lumbar Interbody Fusion (TLIF) procedures for the treatment of subjects with symptomatic degenerative disc disease (DDD).

Conditions

  • Degenerative Disc Disease

Interventions

DEVICE

treatment of degenerative disc disease using the PROW LIF

TLIF procedure for the treatment of degenerative disc disease using the PROW LIF procedure (system)

Sponsors & Collaborators

  • NLT Spine

    lead INDUSTRY

Principal Investigators

  • Joseph Leitner, MD Dr. · Head of the Spine surgery department, Meir Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01850537 on ClinicalTrials.gov